Disease: Acute non lymphoblastic leukemia (generic term)
- A Case of Myelodysplastic Syndrome Developed during Chemotherapy for Postoperative Recurrent Ovarian Cancer That Progressed to Acute Myeloid Leukemia
- A case of pancreatic PEComa with prominent inflammatory cell infiltration: the inflammatory subtype is a distinct histologic group of PEComa
- A Case Report of Chronic Myelogenous Leukemia Presenting as Blastic Crisis with a T-Cell Acute Lymphoblastic Leukemia Phenotype: Awareness of a Rare Entity
- A systematic review and meta-analysis of CD22 CAR T-cells alone or in combination with CD19 CAR T-cells
- Acute Promyelocytic Leukemia Treatment Masking Hepatic Tuberculosis: A Management Dilemma
- Adapter CAR T cells to counteract T-cell exhaustion and enable flexible targeting in AML
- Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission
- Applications of Circulating Tumor DNA in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Promises and Challenges
- Biological interactions of polystyrene nanoplastics: Their cytotoxic and immunotoxic effects on the hepatic and enteric systems
- Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review
- Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies: A Practical Review
- Chronic Myeloid Leukemia following Exposure to Radioactive Iodine (I131): A Systematic Review
- Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study
- Control of acute myeloid leukemia and generation of immune memory in vivo using AMV564, a bivalent bispecific CD33 x CD3 T cell engager
- Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicity
- Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial
- Foretinib Is Effective in Acute Myeloid Leukemia by Inhibiting FLT3 and Overcoming Secondary Mutations That Drive Resistance to Quizartinib and Gilteritinib
- FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients-efficacy and microbiologic safety
- Fulminant Clostridioides difficile infection during treatment with FLT3 inhibitor for acute myeloid leukemia
- Functional diversification and dynamics of CAR-T cells in patients with B-ALL
- Genetic susceptibility and late bone outcomes in childhood acute lymphoblastic leukemia survivors
- Gilteritinib Affects the Selection of Dominant Clones in Clonal Hematopoiesis: Sequential Genetic Analysis of an <em>FLT3</em>-ITD Positive AML Patient with Long-Term Gilteritinib Therapy
- Hematopoietic stem cell microtransplantation in patients aged over 70 with acute myeloid leukemia: a multicenter study
- High Mitochondrial Protein Expression as a Potential Predictor of Relapse Risk in Acute Myeloid Leukemia Patients with the Monocytic FAB Subtypes M4 and M5
- How I treat long-term survivors of childhood acute leukemia
- Human plasma cells engineered to secrete bispecifics drive effective <em>in vivo</em> leukemia killing
- Immune cell therapy for acute myeloid leukemia
- Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two Decades
- Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience
- Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies
- Inhibition of PLK4 remodels histone methylation and activates immune response via cGAS-STING pathway in TP53 mutated AML
- Inhibition of PLK4 remodels histone methylation and activates the immune response via the cGAS-STING pathway in TP53-mutated AML
- Leukemia Cutis
- Long-term experience in treatment of acute promyelocytic leukemia in Mexican children in a tertiary care hospital
- Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant: An Open-Label Randomized Clinical Trial
- Outcome of hematopoietic stem cell transplantation in pediatric patients with acute lymphoblastic leukemia not in remission enrolled in JACLS ALL-02
- Practice preferences for consolidative HSCT following tisagenlecleucel in children and young adults with B-ALL
- Prognostic impact of peripheral blood WT1 mRNA dynamics in patients with acute myeloid leukemia treated with venetoclax combination therapy
- Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A Center for International Blood and Marrow Transplant Research Analysis
- Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis
- Relationship between comorbidities, mutational profile, and outcome after intensive chemotherapy in patients older than 60 years with acute myeloid leukemia: Assessment of different risk scores
- SETBP1 is dispensable for normal and malignant hematopoiesis
- The dilemmas and possible solutions for CAR-T cell therapy application in solid tumors
- The pediatric leukemia oncoprotein NUP98-KDM5A induces genomic instability that may facilitate malignant transformation
- TP53 Mutations in AML Patients Are Associated with Dismal Clinical Outcome Irrespective of Frontline Induction Regimen and Allogeneic Hematopoietic Cell Transplantation
- Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial
- Venetoclax combined with hypomethylating agents and the CAG regimen in relapsed/refractory AML: a single-center clinical trial
- What Influences the Decision to Proceed to Transplant for Patients With AML in First Remission?
- Work Disability and Return to Work After Treatment for Acute Lymphoblastic Leukemia: A Danish Nationwide Cohort Study